Dr. Cassaday’s research interests and clinical practice are almost exclusively devoted to adults with ALL. He is the Principal Investigator on investigator-initiated and industry-sponsored clinical trials in adult ALL. He has particular interests in developing novel chemotherapy strategies for high-risk populations (including older adults and those with relapsed/refractory disease) as well as the use of measurable residual disease (MRD) as a risk-stratification tool in both standard and investigational therapies.
Seattle Cancer Care Alliance825 Eastlake Ave E, Box 358081, Mailstop CE3-300Seattle, WA 98109
Acute lymphoblastic leukemia/lymphoma in adults